Does tigecycline need dosage adjustments with other drugs?
Tigecycline, an antibiotic for complicated infections, requires no dosage adjustments when co-administered with most drugs due to its minimal cytochrome P450 involvement and primary biliary/fecal elimination.[1] Its pharmacokinetics show low potential for interactions affecting tigecycline levels.
Which specific drugs might require tigecycline dose changes?
No routine adjustments are needed for common CYP450 modulators like warfarin, digoxin, or oral contraceptives. However, tigecycline can reduce levels of drugs relying on P-glycoprotein efflux, such as cyclosporine (by up to 70% AUC reduction) or tacrolimus—monitor levels and adjust those drugs if co-used.[1][2]
What about hepatic or renal impairment with concomitant meds?
Dose adjustments apply for tigecycline itself in severe hepatic impairment (50% reduction to 25 mg IV q12h after 100 mg load), regardless of other drugs. No renal adjustments needed. Concurrent hepatotoxic drugs (e.g., acetaminophen overdose) amplify risk without changing tigecycline dose—monitor liver function closely.[1][3]
How do food or antacids affect tigecycline dosing?
Administered IV only, so no food interactions. Avoid concurrent multivalent cations (e.g., magnesium/aluminum in antacids, calcium, iron supplements) within 2-3 hours, as they chelate tigecycline and reduce absorption if oral analogs were used—but tigecycline is IV, minimizing this issue.[1]
Are there warfarin or other anticoagulant interactions?
Tigecycline mildly prolongs INR (1.4-fold increase observed); monitor INR closely and adjust warfarin dose as needed, not tigecycline.[1][2]
What do clinical studies and labels say about interactions?
Phase 3 trials and post-marketing data confirm low interaction risk; FDA label lists no tigecycline dose changes but flags monitoring for cyclosporine, tacrolimus, and warfarin. EMA guidance aligns.[1][3]
Sources
[1]: Tygacil (tigecycline) Prescribing Information - Pfizer
[2]: Drug Interactions with Tigecycline - Clinical Pharmacology Review
[3]: Tigecycline Summary of Product Characteristics - EMA